Phytoestrogens for vasomotor menopausal symptoms

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Lethaby, Anne E ^a   Brown, J ^b   Marjoribanks, J ^b   Kronenberg, F ^b   Roberts, H ^b   Eden, J ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b NONE

Author keywords

Female; Hot flashes *drug therapy ; Humans; Isoflavones therapeutic use ; Phytoestrogens *therapeutic use ; Randomized controlled trials as topic; Soybeans; Sweating *drug effects ; Trifolium

Indexed keywords

GENISTEIN; HUMULUS LUPUTUS EXTRACT; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; PLACEBO; PLANT EXTRACT; PUERARIA EXTRACT; RED CLOVER EXTRACT; SOY EXTRACT;

CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; LINSEED; MENOPAUSE; NIGHT SWEAT; REVIEW; SOYBEAN; VASOMOTOR REFLEX;

EID: 44949170662     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001395.pub3     Document Type: Review

References (145)

1. Albertazzi 1998 {published data only} *Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstetrics and Gynecology 1998;91:6-11.
2. Albertazzi P, Pansini F, Bottazzi M, Bonaccorsi G, de Aloysio D, Morton S. Dietary soy suplementation and phytooestrogen levels. Obstetrics and Gynecology 1999;94(2):229-31.
3. Pansini F, Albertazzi P, Bonaccorsi G, Zanotti C, Campobasso C, Negri C, de Aloysio D, Mollica G, Bottiglioni F. Soy and Hot Flushes. 8th International Congress on the Menopause, Sydney, Australia. 3-7 November 1996.
4. Baber 1999 {published data only} Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999;2:85-92.
5. Balk 2002 {published data only} Balk JL, Whiteside DA, Naus G, DeFerrari E, Roberts JM. A pilot study of the effects of phytoestrogen supplementation on the postmenopausal endometrium. J Soc Gynecol Investig 2002;9:238-42.
6. Bicca 2004 {unpublished data only} *Bicca ML de O, Horta BL, Lethaby AE. Double-blind randomized clinical trial to assess the effectiveness of soy isoflavones in the relief of climacteric symptoms.
7. Brzezinski 1997 {published data only} Brzezinski A, Adlercreutz H, Shaoul R, Rosler A, Shmueli A, Tanos V, Schenker JG. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause: The Journal of the North American Menopause Society 1997;4(2):89-94.
8. Burke 2003 {published data only} Burke GL, Legault C, Anthony M, Bland DR, Morgan TM, Naughton MJ, et al.Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study. Menopause 2003;10(2):147-153.
9. Campagnoli 2005 {published data only} Campagnoli C, Abba C, Ambroggio S, Peris C, Perona M, Sanseverino P. Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement. Maturitas 2005;51:127-34.
10. Crisafulli 2004 {published data only} Crisafulli A, Marini H, Bitto A, Altavilla D, Squadrito G, Romeo A, et al.Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo- controlled study. Menopause 2004;11:400-404.
11. Dalais 1998 {published data only} Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, et al.Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1998;1:124-9.
12. Dodin 2005 {published data only} Dodin S, Lemay A, Jacques H, Legare F, Forest J-C, Masse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. Journal of Clinical Endocrinology and Metabolism 2004;90(3):1390- 7.
13. Duffy 2003 {published data only} Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacology, Biochemistry and Behaviour 2003;75:721-9.
14. Faure 2002 {published data only} Faure ED, Chantre P, Mares P. Effects of a standardised soy extract on hot flushes: a multicentre, double-blind, randomised placebo-controlled study. Menopause: Journal of the North American Menopause Society 2002;9(5):329-34.
15. Han 2002 {published data only} Han KK, Soares JM, Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology 2002;99:389-94.
16. Heyerick 2006 {published data only} Heyerick A, Vervarcke S, Depypere H, Bracke M, De Keukeleire D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 2006;54:164-75.
17. Hidalgo 2005 {published data only} Hidalgo LA, Chedraui PA, Morocho N, Ross S, San Miguel G. The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study. Gynecological Endocrinology 2005;21(5):257-64.
18. Imhof 2006 {published data only} Imhof M, Gocan A, Reithmayer F, Lipovac M, Schimitzek C, Chedraui P, Huber J. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas 2006;55:76-81.
19. Jeri 2002 {published data only} Jeri A. The use of an isoflavone supplement to relieve hot flushes. The Female Patient 2002;27:47-9.
20. Kaari 2006 {published data only} Kaari C, Haidar MA, Soares Junior JM, Nunes MG, de Azevedo Quadros LG, Kemp C, Stavele JN, Baracat EC. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas 2006;53:49-58.
21. Khaodhiar 2007 {unpublished data only} Khaodhiar L, Ricciotti HA, Li L, Pan W, Schickel M, Zhou J, Blackburn GL. Daidzein-rich isoflavone-aglycones are effective in reducing hot flashes in menopausal women. in press 2007.
22. Knight 1999 {published data only} Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999;2:79-84.
23. Knight 2001 {published data only} Knight DC, Howes JB, Eden JA, Howes LG. Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation. Climacteric 2001;4:13-8.
24. Kotsopoulos 2000 {published data only} Kotsopoulos D, Dalais FS, Liang Y-L, McGrath BP, Teede HJ. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 2000;3:161-7.
25. Lewis 2006 {published data only} Lewis JE, Nickell LA, Thompson LU, Szalai JP, Kiss A, Hilditch JR. A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause 2006;13(4):631-42.
26. Penotti 2003 {published data only} Penotti M, Fabio E, Modena AB, Rinaldi M, Omodei U, Vigano P. Effect of soy-derived isoflavones on hot flushes, endometrial thickness and the pulsatility index of the uterine and cerebral arteries. Fertility and Sterility 2003;79(5):1112-7.
27. Penotti M, Fabio E, Rinaldi M, Omodei U, Bacchi M. Effects of soy-derived isoflavones on hot flushes and vascular reactivity. The 10th World Congress on the Menopause. Abstract F-27-01. June 2002.
28. Sammartino 2003 {published data only} Sammartino A, Di Carlo C, Mandato VD, Bifulco G, De Stefano M, Nappi C. Effects of genistein on the endometrium: ultrasonographic evaluation. Gynecological Endocrinology 2003;17(1):45-9.
29. St Germain 2001 {published data only} St Germain A, Peterson CT, Robinson JG, Alekel DL. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause: J Nth Amer Menop Soc 2002;8(1):17-26.
30. Tice 2003 {published data only} Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA 2003;290(2):207-14.
31. Upmalis 2000 {published data only} Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter double-blind randomized placebo-controlled study. Menopause: Journal of the North American Menopause Society 2000;7(4):236-42.
32. van De Weijer 2002 {published data only} van de Weijer PHM, Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002;42:187-193.
33. Woo 2003 {published data only} Woo J, Lau E, Ho SC, Cheng F, Chan C, Chan AS, et al.Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause 2003;10(4):352-61.
34. Albert 2001 Albert A, Altabre C, Baro F, Cabero A, Cancelo MJ, Castelo-Branco C, et al.Assessment of the efficiency and safety of soya-extracted phytoestrogens (Glycine Max L), in the treatment of climacteric symptoms. Results of a mulicenter, open, propsective pilot study [Valoracion de la eficacia y seguridad de una preparacion de fitoestrogenos extraidos de la soja (Glycine Max L.) en al tratamiento de la sintomatologia climaterica. Resultados de un ensayo piloto multicentrico, abierto y prospectivo]. Toko-ginecologia Practica 2001;60(5):257-64.
35. Albertazzi 2005 Albertazzi P, Steel SA, Bottazzi M. Effect of pure genistein on bone markers and hot flushes. Climacteric 2005;8(4):371-9.
36. Atkinson 2003 Atkinson C, Warren RML, Sala E, Dowsett M, Dunning AM, Healey CS, et al.Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial. Breast Cancer Research 2004;6(3):R170-9.
37. Baird 1995 Baird DB, Umbach DM, Lansdell L, Hughes CL, Setchell KDR, Weinberg CR, et al.Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. The Journal of Clinical Endocrinology and Metabolism 1995;80(5):1685-90.
38. Cancellieri 2007 Cancellieri F, De Leo V, Genazzani AD, Nappi C, Parenti GL, Polatti F, Ragni N, Savoca S, Teglio L, Finelli F, Nichelatti M. Efficacy on menopausal neurovegetative symptoms and some plasma lipids blood levels of an herbal product containing isoflavones and other plant extracts. Maturitas 2007;56:249-56.
39. Carranza-Lira 2001 Carranza-Lira SC, Barahona OF, Ramos DP, Herrera J, Olivares-Segura A, Cardoso G, et al.Changes in symptoms, lipid and hormone levels after the administration of a cream with phytoestrogens in the climacteric - preliminary report. International Journal of Fertility 2001;46(6):296-9.
40. Chiechi 2003 Chiechi LM, Putignano G, Guerra V, Schiavelli MP, Cisternino AM, Carriero C. The effect of a soy rich diet on the vaginal epithelium in postmenopause: a randomized double blind trial. Maturitas 2003;45:241-6.
41. Colacurci 2004 Colacurci N, Zarcone R, Borrelli A, De Franciscis P, Fortunato N, Cirillo M, Fornaro F. Effects of soy isoflavones on menopausal neurovegetative symptoms. Minerva Ginecologica 2004;56(5):407-12.
42. Duncan 1999 Duncan AM, Underhill KEW, Xu X, LaValleur J, Phipps WR, Kurzer MS. Modest hormonal effects of soy isoflavones in postmenopausal women. The Journal of Clinical Endocrinology and Metabolism 1999;84(10):3479-84.
43. Hale 2001 Hale GE, Hughes CL, Robboy SJ, Agarwal SK, Bievre M. A double-blind randomised study on the effects of red clover isoflavones on the endometrium. Menopause 2001;8(5):338-46.
44. Harding 1996 Harding C, Morton M, Gould V, McMichael Phillips D, Howell A, Bundred NJ. Dietary soy supplementation is oestrogenic in menopausal women (poster abstract). Second International Symposium on the role of soy in preventing and treating chronic disease, Sept 15-18 1996, Brussells, Belgium. 1996.
45. Hochanadel 1999 Hochanadel G, Shifren I, Zhdanova I, Maher T, Spiers P. Soy isoflavones (phytoestrogens) in the treatment of the cognitive and somatic symptoms of menopause. Fertility and Sterility 1999;71(4):22.
46. Jou 2005 Jou HJ, Ling PY, Wu SC. Comparison of 70mg and 35mg isoflavone soya supplement for menopause symptoms. International Journal of Gynaecology and Obstetrics 2005;90(2):156-60.
47. Kok 2005 *Kok L, Kreijkamp-Kaspers S, Grobbee DE, Lampe JW, van der Schouw YT. A randomized placebo-controlled trial on the effects of soy protein containing isoflavones on quality of life in postmenopausal women. Menopause 2005;12(1):56-62.
48. Kok L, Kreijkamp-Kaspers S, Grobbee DE, van der Schouw YT. Design and baseline characteristics of a trial on health effects of soy protein with isoflavones in postmenopausal women. Maturitas 2004;47:21-9.
49. Lamlertkittikul 2004 Lamlertkittikul S, Chandeying V. Efficacy and safety of Puerariamirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: phase II study. Journal of the Medical Association of Thailand 2004;87:33-40.
50. Manonai 2006 Manonai J, Songchitsomboon S, Chanda K, Hong JH, Komindr S. The effect of a soy-rich diet on urogenital atrophy: a randomized crossover trial. 2006 Maturitas;54:135-40.
51. Murkies 1995 Murkies AL, Lombard C, Strauss BJG, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas 1995;21:189-95.
52. Nahas 2004 Nahas EP, Neto JN, de Luca L, Traiman P, Pontes A, Dalben I. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas 2004;48(4):372-80.
53. Newton 2006 *Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy or placebo. Annals of Internal Medicine 2006;145:869-79.
54. Newton KM, Reed SD, La Croix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Principal results of the herbal alternatives for menopause (HALT) study. 16th annual meeting of the North American Menopause Society. 2005:S-13.
55. Reed SD, Newton KM, Grothaus L, Ehrlich K, Grieco V, La Croix AZ. Vaginal findings from a randomized placebo-controlled trial of black cohosh, multibotannical herbs and dietary soy for hot flushes: the herbal alternatives (HALT) study. 7th European Congress on Menopause. 2006:s102-3.
56. Reed SD, Newton KM, Grothaus L, Ehrlich K, Schenk J, La Croix AZ. The herbal alternative for menopause study (HALT: dietary soy intervention). 7th European Congress on Menopause. 2006:s63.
57. Reed SD, Newton KM, La Croix AZ, Grothaus LA, Ehrlich K, Guiltinan K. The herbal alternatives for menopause (HALT) study: endometrial safety. 16th annual meeting of the North American Menopause Society. 2005:P-70.
58. Nikander 2005 Nikander E, Rutanen E-M, Nieminen P, Wahlstrom T, Ylikorkala O, Tiitinen A. Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women. Fertility and Sterility 2005;83(1):137-42.
59. Quella 2000 Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, Swan D, Krupp KR, Miller KD, Novotny PJ. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment trial. Journal of Clinical Oncology 2000;18(5):1068-74.
60. Russo 2003 Russo R, Corosu R. The clinical use of a preparation based on phytoestrogens in the treatment of menopausal disorders. Acta Bio-Medica de l Ateneo Parmense 2003;74(3):137-43.
61. Sammartino 2006 Sammartino A, Tommaselli GA, Gargano V, Di Carlo C, Attianese W, Nappi C. Short-term effectgs of a combination of isoflavones, lignans and Cimicifuga racemosa on climacteric-related symptoms in postmenopausal women: a double-blind randomized placebo-controlled trial. Gynecological Endocrinology 2006;22(11):646-50.
62. Scambia 2000 Scambia G, Mango D, Signorile PG, Angeli RA, Palena C, Gallo D, et al.Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 2000;7(2):105-11.
63. Secreto 2003 Secreto G, Chiechi LM, Amadori A, Miceli R, Venturelli E, Valerio T, Marubini E. Soy isoflavones andmelatonin for the relief of climcteric symptoms: a multicenter, double blind, randomized study. Maturitas 2004;47:11-20.
64. Uesugi 2004 Uesugi S, Watanabe S, Ishiwata N, Uehara M, Ouchi K. Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese women. BioFactors 2004;22:221-8.
65. Unfer 2004 Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. Endometrial effects of long-termtreatment with phytoestrogens: a randomized double-blind placebo-controlled study. Fertility and Sterility 2004;82(1):145-8.
66. van Patten 2002 van Patten CL, Olivotto IA, Chambers GK, et al.Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomised controlled clinical trial. Journal of Clinical Oncology 2002;20(6):1449-55.
67. Verhoeven 2005 Verhoeven MO, van der Mooren MJ, van de Weijer PHM, Verhegem PJE, van der Burgt LMJ, Kenemans P. Effect of a combination isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. Menopause 2005;12(4):412-20.
68. Washburn 1999 Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6;1:7-13.
69. Xue 2004 Xue X, Niu J, Wang J, Ai H. A prospective controlled study on the clinical therapeutic effect of treatment of menstrual syndrome by isoflavone of soybean. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004;24(9):835-6.
70. Agrawal 2005
71. Amato 2005
72. Brzezinski 1999
73. Casserta 2005
74. Cheng 2007
75. D'Anna 2007
76. Jeri 1999
77. Kolarov 2001
78. Nachtigall 1999
79. Paixao 2005
80. Stanosz 2006
81. Adlercreutz 1987 Adlercreutz H, Hockerstedt K, Bannwart C, Bloigu S, Hamalainen E, Fotsis T, Ollus A. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone blinding globulin (SHBG). Journal of Steroids and Biochemistry 1987;27:1135-44.
82. Adlercreutz 1990 Adlercreutz H. Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scandinavian Journal of Clinical Laboratory Investigations 1990;50(Suppl):3-23.
83. Adlercreutz 1995 Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environmental Health Perspectectives 1995;103(Suppl 7):103-12.
84. AFSSA 2005 AFSSA Working Group. Safety and benefit of phytoestrogens - recommendations. INSERM-CRLC M, France 2005:1-8.
85. Alder 1998 Alder, E. The Blatt-Kupperman menopausal index: a critique. Maturitas 1998;29:19-24.
86. Anderson 2003 Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, et al.Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA 2003;290(13):1739-48.
87. Bakken 2004 Bakken K, Eggen AE, Lund E. Side-effects of hormone replacement therapy and influence in pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997. Acta Obstetrica Gynecologica Scandinavica 2004;83(9):850-6.
88. Bennetts 1946 Bennetts HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Australian Vetinary Journal 1946;22:2-12.
89. Beral 2003 Beral V. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362(9382):419-27.
90. Bestul 2004 Bestul MB, McCollum M, Hansen LB, Saseen JJ. Impact of the women's health initiative trial results on hormone replacement therapy. Pharmacotherapy 2004;24(4):495-9.
91. Bjorn 1999 Bjorn I, Backsrom T. Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy. Maturitas 1999;32(2):77-86.
92. Blair 2005 Blair YA, Gold EB, Azari RA, et al.Use of conventional and complementary health care during the transition to menopause: longitudinal results from the Study of Women's Health Across the Nation (SWAN). Menopause 2005;12:31-9.
93. Boulet 1994 Boulet MJ, Oddens BJ, Lehert P, Verner HM, Visser A. Climacteric and menopause in seven south-east Asian countries. Maturitas 1994;19:205-9.
94. Cassidy 1993 Cassidy A, Bingham S, Carlson J, Setchell KDR. Biological effects of plant estrogens in premenopausal women. FASEB J 1993;A:866.
95. Cassidy 1994 Cassidy A, Bingham S, Setchell KDR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. The American Journal of Clinical Nutrition 1994;60:333-40.
96. Com Tox 2003 Committee on Toxicity. Phytoestrogens and health. London, 2003:1-444.
97. Europ Med Ag 2006 European Medicines Agency. Evaluation of Medicines for Human Use. Guidelines for hormone replacement therapy. www.emea.eu.int, accessed 20/01/06 Vol. 2006.
98. Freedman 1995 Freedman RR, Norton D, Woodward S, Cornelissen G. Core body temperature and circadian rhythm of hot flashes in menopausal women. Clinical Endocrinology and Metabolism 1995;80(8):2354-8.
99. Freedman 2001 Freedman RR. Physiology of hot flashes. American Journal of Human Biology 2001;13(4):453-64.
100. Freeman 2001 Freeman EW, Grisso JA, Berlin J, Sammel M, Garcia-Espana B, Hollander L. Symptom reports from a cohort of African American and white women in the late reproductive years. Menopause 2001;8:33-42.
101. Freeman 2007 Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007;10:197-214.
102. Geller 2005 Geller SE, Studee L. Botanical and dietary supplements for menopausal symptoms: what works, what does not. Journal of Women's Health 2005;14(7):634-49.
103. Glazier 2001 Glazier MG, Bowman MA. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Archives of Internal Medicine 2001;161:1161-72.
104. Gold 2006 Gold EB, Colvin A, Avis N, Bromberger J, Greendate GA, Powell L, et al.Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of womens' health across the nation. American Journal of Public Health 2006;96(7):1226-35.
105. Gold 2007 Gold EB, Bair Y, Zhang G, Utts J, Greendate GA, Upchurch D, Chyu L, Sternfeld B, Adler S. Cross-sectional analysis of specific complementary and alternative medicine (CAM) use by racial/ethnic group and menopausal status: the Study of Women's Health Across the Nation (SWAN). Menopause 2007;14(4):612-23.
106. Grady 2000 Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, et al.Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/Progestin Replacement Study. Annals of Internal Medicine 2000;132(9):689-96.
107. Haas 2004 Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Annals of Internal Medicine 2004;140(3): 184-8.
108. Haimov-Kochman 2005 Haimov-Kochman R, Hchner-Celnikier D. Hot flashes revisited: pharmacological and herbal options for hot flush management. What does the evidence tell us?. Acta Obstetrica Gynecologica Scandinavica 2005;84:972-9.
109. Howes 2006 Howes LG, Howes JB, Knight DC. Isoflavone therapy for menopausal flushes: a systematic review andmeta-analysis. Maturitas 2006;55:203-11.
110. Hulley 1998 Hulley S, Grady D, Bush T. Randomised controlled trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/Progestin Replacement Study (HERS). JAMA 1998;280:605-13.
111. Huntley 2004 Huntley AL, Ernst E. Soy for the treatment of perimenopausal symptoms - a systematic review. Maturitas 2004;47:1-9.
112. Knight 1996 Knight D, Eden JA. A review of the clinical effects of phytoestrogens. Obstetrics and Gynecology 1996;87:897-904.
113. Krebs 2004 Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstetrics and Gynecology 2004;104(4):824-36.
114. Kronenberg 1987 Kronenberg F, Downey JA. Thermoregulatory physiology of menopausal hot flashes: a review. Canadian Journal of Physiology and Pharmacology 1987;65(6):1312-24.
115. Kronenberg 1990 Kronenberg F. Hot flashes: epidemiology and physiology. Annals of the New York Academy of Sciences 1990;592:52-86.
116. Lock 1988 Lock M, Kaufert P, Gilbert P. Cultural construction of the menopausal syndrome: the Japanese case. Maturitas 1988;10:317-332.
117. Lock 1991 Lock M. Contested meanings of the menopause. Lancet 1991;337:1270-2.
118. Low Dog 2005 Low Dog, T. Menopause: a review of botanical dietary supplements. American Journal of Medicine 2005;118(12B):98-108.
119. MacLennan 1999 MacLennan A. The four harms of harmless therapies (editorial). Climacteric 1999;2:73-4.
120. Mahady 2003 Mahady GB, Parrot J, Lee C, Yun GS, Dan A. Botanical dietary supplement use in per- and postmenopausal women. Menopause 2003;10:65-72.
121. Makela 1994 Makela S, Davis VL, Tally WC. Dietary estrogens act through estrogen-receptor mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environmental Health Perspectives 1994;102:572-8.
122. Milligan 1999 Milligan SR, Kalita JC, Heyerick A, Rong H, De Cooman L, De Keukeleire D. Identification of a potent phytoestrogen in hops (Humulus luputus L.) and beer. The Journal of Clinical Endocrinology and Metabolism 1999;84:2249-2252.
123. Nagata 2001 Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. American Journal of Epidemiology 2001;153:790- 3.
124. NAMS 2004 North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause 2004;11:11-33.
125. Nedrow 2006 Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms. Archives of Internal Medicine 2006;166:1453-65.
126. Newton 2002 Newton KM, Buist DSM, Keenan NL, Anderson LA, LaCroix AZ. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstetrics and Gynecology 2002;100:18-25.
127. NZGG 2004 Hormone replacement therapy: best practice evidence-based guideline. www.nzgg.org.nz 2004.
128. Roussouw 2002 Roussouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized trial. JAMA 288;3:321-33.
129. Rowland 2003 Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A. Bioavailability of phyto-oestrogens. British Journal of Nutrition 2003;Suppl:45-48.
130. Setchell 1984 Setchell KDR, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal oestrogens of dietary origin; possible role in hormone dependent disease. The American Journal of Clinical Nutrition 1984;2:49-56.
131. Setchell 1997 Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phytoestrogens from soy-based infant formula. Lancet 1997;350:23-27.
132. Setchell 1998 Setchell KDR. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. The American Journal of Clinical Nutrition 1998;68 Suppl:1333-46.
133. Setchell 2002 Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. Journal of Nutrition 2002;132:3577-3584.
134. Sievert 2007 Sievert LL, Morrison L, Brown DE, Reza AM. Vasomotor symptoms among Japanese-American and European-American women living in Hilo, Hawaii. Menopause 2007;14(2):261-269.
135. Sikon 2004 Sikon A, Thacker HL. Treatment options formenopausal hot flashes. Seminars in Reproductive Medicine 2004;71:578-82.
136. Somekawa 2001 Somekawa Y, Chiguchi M, Ishibashi T, Aso T. Soy intake related to menopausal symptoms, serum lipids and bone mineral density in postmenopausal Japanese women. Obstetrics and Gynecology 2001;97:109-15.
137. Thompson 1973 Thompson B, Hart SA, Dumo D. Menopausal age and symptomatology in a general practice. Journal of Biosocial Science 1973;5:71-82.
138. Thompson 1991 Thompson LU, Robb P, Serraino M. Mammalian lignan production from various foods. Nutrition and Cancer 1991;16:43-52.
139. Travers 2006 Travers C, O'Neill SM, Khoo S-K, King R. Hormones down under. Hormone therapy use after the Women's Health Initiative. Australian and New Zealand Journal of Obstetrics and Gynaecology 2006;46:330-5.
140. UK CSM 2003 UK Committee for Safety and Medicine. HRT: update on the risk of breast cancer and long-term safety. Current Problems in Pharmacovigilance 2003;29:1-3.
141. Viscoli 2001 Viscoli CM, Brass LM, Kernan WN, et al.A clinical trial of estrogen replacement therapy after ischemic stroke. New England Journal of Medicine 2001;345:1243-9.
142. WHO 1996 World Health Organisation Scientific Group. Menopause. WHO Technical Report Series, 866 1996; Vol. 7, issue 4:236-42.
143. Wilcox 1990 Wilcox G, Wahlqvist ML, Burger HG, Medley G. Oestrogenic effects of plant foods in postmenopausal women. BMJ 1990;301:905-6.
144. Williamson-H 2006 Williamson-Hughes PS, Flickinger BD, Messina MJ, Empie MW. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause 2006;13(5):831-9.
145. Wiseman 2004 Wiseman H, Casey K, Bowey EA, et al.Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. The American Journal of Clinical Nutrition 2004;80(3):692-9.